Literature DB >> 25392702

PET-directed, 3D Ultrasound-guided prostate biopsy.

Baowei Fei1, Peter T Nieh2, David M Schuster3, Viraj A Master2.   

Abstract

Multimodatity imaging is a promising approach for improving prostate cancer detection and diagnosis. This article describes various concepts in PET-directed, ultrasound-guided biopsies and highlights a new PET/ultrasound fusion targeted biopsy system for prostate cancer detection.

Entities:  

Year:  2013        PMID： 25392702      PMCID： PMC4225556     

Source DB:  PubMed          Journal:  Diagn Imaging Eur        ISSN： 1461-0051


  10 in total

1.  3D ultrasound image segmentation using wavelet support vector machines.

Authors:  Hamed Akbari; Baowei Fei
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

2.  3D Non-rigid Registration Using Surface and Local Salient Features for Transrectal Ultrasound Image-guided Prostate Biopsy.

Authors:  Xiaofeng Yang; Hamed Akbari; Luma Halig; Baowei Fei
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-03-01

3.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

Review 4.  MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.

Authors:  H Hricak
Journal:  Br J Radiol       Date:  2005       Impact factor: 3.039

5.  Clinical application of a 3D ultrasound-guided prostate biopsy system.

Authors:  Shyam Natarajan; Leonard S Marks; Daniel J A Margolis; Jiaoti Huang; Maria Luz Macairan; Patricia Lieu; Aaron Fenster
Journal:  Urol Oncol       Date:  2011 May-Jun       Impact factor: 3.498

6.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.

Authors:  Peter A Pinto; Paul H Chung; Ardeshir R Rastinehad; Angelo A Baccala; Jochen Kruecker; Compton J Benjamin; Sheng Xu; Pingkun Yan; Samuel Kadoury; Celene Chua; Julia K Locklin; Baris Turkbey; Joanna H Shih; Stacey P Gates; Carey Buckner; Gennady Bratslavsky; W Marston Linehan; Neil D Glossop; Peter L Choyke; Bradford J Wood
Journal:  J Urol       Date:  2011-08-17       Impact factor: 7.450

7.  Choline PET for monitoring early tumor response to photodynamic therapy.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Song-mao Chiu
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

8.  Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.

Authors:  David M Schuster; Pooneh A Taleghani; Peter T Nieh; Viraj A Master; Rianot Amzat; Bital Savir-Baruch; Raghuveer K Halkar; Tim Fox; Adeboye O Osunkoya; Carlos S Moreno; Jonathon A Nye; Weiping Yu; Baowei Fei; Zhibo Wang; Zhengjia Chen; Mark M Goodman
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

9.  Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer.

Authors:  K A Iczkowski; T J Bassler; V S Schwob; I C Bassler; B S Kunnel; R E Orozco; D G Bostwick
Journal:  Urology       Date:  1998-05       Impact factor: 2.649

10.  Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.

Authors:  David Schilling; Heinz P Schlemmer; Philipp H Wagner; Patrick Böttcher; Axel S Merseburger; Philip Aschoff; Roland Bares; Christa Pfannenberg; Ute Ganswindt; Stefan Corvin; Arnulf Stenzl
Journal:  BJU Int       Date:  2008-04-11       Impact factor: 5.588
  10 in total
  9 in total

1.  Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  Clin Transl Imaging       Date:  2017-04-10

Review 2.  PET Molecular Imaging-Directed Biopsy: A Review.

Authors:  Baowei Fei; David M Schuster
Journal:  AJR Am J Roentgenol       Date:  2017-05-15       Impact factor: 3.959

3.  Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.

Authors:  Baowei Fei; Olayinka A Abiodun-Ojo; Akinyemi A Akintayo; Oladunni Akin-Akintayo; Funmilayo Tade; Peter T Nieh; Viraj A Master; Mehrdad Alemozaffar; Adeboye O Osunkoya; Mark M Goodman; David M Schuster
Journal:  J Urol       Date:  2019-07-08       Impact factor: 7.450

4.  A supervoxel-based segmentation method for prostate MR images.

Authors:  Zhiqiang Tian; Lizhi Liu; Zhenfeng Zhang; Jianru Xue; Baowei Fei
Journal:  Med Phys       Date:  2017-02       Impact factor: 4.071

5.  18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.

Authors:  Olayinka A Abiodun-Ojo; Akinyemi A Akintayo; Oladunni O Akin-Akintayo; Funmilayo I Tade; Peter T Nieh; Viraj A Master; Mehrdad Alemozaffar; Adeboye O Osunkoya; Mark M Goodman; Baowei Fei; David M Schuster
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

6.  Molecular imaging and fusion targeted biopsy of the prostate.

Authors:  Baowei Fei; Peter T Nieh; Viraj A Master; Yun Zhang; Adeboye O Osunkoya; David M Schuster
Journal:  Clin Transl Imaging       Date:  2016-12-01

7.  Deformable registration of PET/CT and ultrasound for disease-targeted focal prostate brachytherapy.

Authors:  Sharmin Sultana; Daniel Y Song; Junghoon Lee
Journal:  J Med Imaging (Bellingham)       Date:  2019-09-12

8.  Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR).

Authors: 
Journal:  Insights Imaging       Date:  2015-03-13

9.  68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study.

Authors:  Le-Le Zhang; Wen-Cheng Li; Zheng Xu; Nan Jiang; Shi-Ming Zang; Lu-Wei Xu; Wen-Bing Huang; Feng Wang; Hong-Bin Sun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-30       Impact factor: 9.236
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.